ORIC

7.3504.55%
PS

Pratik S. Multani

Chief Medical Officer

Dr. Pratik S. Multani, M.D., M.S. has been Chief Medical Officer of ORIC Pharmaceuticals, Inc. since September 2018. Dr. Multani served as an Independent Director at Chimerix, Inc. since February 24, 2020 until April 21, 2025. He has been an Independent Director of Erasca, Inc. since July 2018. He has experience advancing oncology products from the clinic through regulatory approval. Dr. Multani joined the ORIC Pharmaceuticals, Inc. in September 2018. Prior to joining ORIC Pharmaceuticals, Dr. Multani served as Chief Medical Officer of Ignyta, Inc. from 2015 to February 2018. Before joining Ignyta, Dr. Multani was Chief Medical Officer of Fate Therapeutics, Inc. from 2009 to 2015. Dr. Multani was Vice President of Clinical Development at Kalypsys, Inc. and Senior Vice President of Clinical Development and Chief Medical Officer at Kanisa Pharmaceuticals, Inc. He held multiple leadership positions at Salmedix, Inc. Dr. Multani started his biotech career at Biogen Idec, Inc., where he was involved with the development of both Zevalin and Rituxan for treatment of Non-Hodgkin Lymphoma. Earlier in his career, Dr. Multani held academic and clinical positions at Harvard Medical School and at Massachusetts General Hospital. His postdoctoral training included a fellowship in hematology and oncology at Dana-Farber Cancer Institute and an internship and residency in internal medicine at Massachusetts General Hospital. He holds a B.S. in chemistry and biology from Yale University. Dr. Multani received an M.D. from Harvard Medical School and an M.S. in clinical epidemiology from Harvard School of Public Health.

Positions